
Immpulse Life Sciences Private Limited
About Immpulse Life Sciences Private Limited
Data last updated:
Immpulse Life Sciences Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2019PTC123371. Its GSTIN is 09AAFCI4685M1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anurag Mishra (Managing Director) and Gyan Chandra Mishra.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Arazi(Az) No. 223 Chak Babura Naini, Allahabad, Uttar Pradesh, India – 211008.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.68 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹2,161 (net margin 0.1%) and EBITDA of ₹3,142 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years.
Company details
Contact details
Immpulse Life Sciences Private Limited's registered office is in Allahabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressArazi(Az) No. 223 Chak Babura Naini, Allahabad, Uttar Pradesh, India – 211008
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Immpulse Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Immpulse Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Immpulse Life Sciences Private Limited, buy the company report.
Financials of Immpulse Life Sciences Private Limited
FY 2025 filings availableImmpulse Life Sciences Private Limited reported revenue of ₹16.68 Lakh (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 68% over three years, including 18% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,142 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,161 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immpulse Life Sciences Private Limited, buy the company report.
Board of directors of Immpulse Life Sciences Private Limited
Immpulse Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Mishra | Managing Director | 15 Nov 2019 | 7 Years 0 Months | Current |
| Gyan Chandra Mishra | Director | 15 Nov 2019 | 7 Years 0 Months | Current |
| Prakash Tiwari | Director | 14 Sep 2021 | 5 Years 2 Months | Current |
Peer comparison
Immpulse Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Palrich Naturals Care Private Limited | ₹16.73 Lakh (FY 2025) | -37.0% | Vapi, Gujarat, India | |||
| Tamagna Personalcare Private Limited | ₹16.72 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| SL Rajesh Chemicals Private Limited | ₹16.7 Lakh (FY 2017) | 98.0% | Rau, Madhya Pradesh, India | |||
| Pramanik Ayurveda Reinvented Private Limited | ₹16.68 Lakh (FY 2025) | 49.0% | Kozhikode, Kerala, India | |||
| Chromtech Bioprocess Private Limited | ₹16.68 Lakh (FY 2024) | 111085.0% | Ahmedabad, Gujarat, India | |||
| Immpulse Life Sciences Private Limitedthis company | ₹16.68 Lakh (FY 2025) | ₹2,161 | 0.1% | 18.0% | Allahabad, Uttar Pradesh, India | |
| Mahalasa Polyplast Private Limited | ₹16.66 Lakh (FY 2025) | 2.0% | Goa, India | |||
| Skinjewells Aesthetics Private Limited | ₹16.64 Lakh (FY 2025) | 11.0% | Pune, Maharashtra, India | |||
| Ms Meruvax Pharma Private Limited | ₹16.61 Lakh (FY 2016) | 730.0% | Hyderabad, Telangana, India | |||
| Medivalens Laboratories Private Limited | ₹16.59 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Chembricks Laboratories Private Limited | ₹16.58 Lakh (FY 2024) | Hyderabad, Telangana, India |
To see the full peer comparison of Immpulse Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Immpulse Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immpulse Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Immpulse Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCI4685M1ZV | Uttar Pradesh | Active | 21 Dec 2020 |
To see the full GST registrations and return filing status of Immpulse Life Sciences Private Limited, buy the company report.
Recent activity
Immpulse Life Sciences Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Prakash Tiwari was appointed as Director on 14 Sep 2021.
Frequently asked questions
Immpulse Life Sciences is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 November 2019 (7+ years old) and is registered under CIN U24230UP2019PTC123371.
Immpulse Life Sciences has 3 current directors:
- Anurag Mishra - Managing Director
- Gyan Chandra Mishra - Director
- Prakash Tiwari - Director
The latest financial statements of Immpulse Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Immpulse Life Sciences is 09AAFCI4685M1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Immpulse Life Sciences is U24230UP2019PTC123371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immpulse Life Sciences was incorporated on 15 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Immpulse Life Sciences by revenue are Palrich Naturals Care Private Limited, Tamagna Personalcare Private Limited, SL Rajesh Chemicals Private Limited, Pramanik Ayurveda Reinvented Private Limited, Chromtech Bioprocess Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prakash Tiwari was appointed as Director on 14 Sep 2021. Anurag Mishra was appointed as Managing Director on 15 Nov 2019. Gyan Chandra Mishra was appointed as Director on 15 Nov 2019.
The registered office of Immpulse Life Sciences is at AraziAz No. 223 Chak Babura Naini, Allahabad, Uttar Pradesh, India – 211008.
Immpulse Life Sciences operates in the chemicals industry, in the manufacturing segment.
Immpulse Life Sciences can be reached at its registered office: AraziAz No. 223 Chak Babura Naini, Allahabad, Uttar Pradesh, India – 211008.

